Related Experiment Video
Updated: Jan 25, 2026

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
Published on: May 10, 2016
Toxicological and pharmacologic effects of farnesol (C15H26O): A descriptive systematic review
Gyllyandeson de Araújo Delmondes1, Daniel Souza Bezerra1, Diógenes de Queiroz Dias1
1Regional University of Cariri (URCA), Crato, CE, Brazil.
Abstract:
The objective of the present study was to perform a systematic review (SR) composed of preclinical and clinical studies which investigated the toxicological and pharmacologic effects of farnesol [Molecular formula: C15H26O; IUPAC: (3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol]. This SR was performed according to PRISMA guidelines. Literature research was performed using PubMed, MEDLINE, Scopus and Web of Science databases using the descriptor combinations: "farnesol and pharmacological effect" and "farnesol and toxicology". The inclusion criteria used were original articles from preclinical and clinical studies investigating the pharmacological and toxicological effects of farnesol, published between January 1960 and December 2017 which were written in English, Portuguese and Spanish. Primary research identified 414 articles, from which 76 articles were selected for final analysis following the inclusion criteria. After grouping, 51.32 and 22.37% of the articles investigated the antimicrobial and antitumor effect, respectively. Methodological biases have been observed both in pre-clinical studies with non-human animals and in clinical trials, mainly in group allocation and blinding. This SR is the first study developed to compile the studies concerning the pharmacological and toxicological effects of farnesol. This study concludes that farnesol possesses different pharmacological and toxicological features, which permit its use as an active or a coadjuvant drug.
Insights
This systematic review of farnesol (C15H26O) reveals diverse pharmacological and toxicological effects. Farnesol shows potential as an active or coadjuvant drug, with significant research into its antimicrobial and antitumor properties.
Area of Science:
- Pharmacology
- Toxicology
- Natural Products Chemistry
Background:
- Farnesol (C15H26O) is a natural acyclic sesquiterpene alcohol with documented biological activities.
- Understanding its pharmacological and toxicological profile is crucial for therapeutic applications.
Purpose of the Study:
- To systematically review preclinical and clinical studies on the pharmacological and toxicological effects of farnesol.
- To consolidate existing research and identify key findings regarding farnesol's therapeutic potential.
Main Methods:
- Systematic review conducted according to PRISMA guidelines.
- Literature search across PubMed, MEDLINE, Scopus, and Web of Science databases.
- Inclusion of English, Portuguese, and Spanish articles published between 1960 and 2017.
Main Results:
- 76 articles were selected from 414 initial records.
- Antimicrobial (51.32%) and antitumor (22.37%) effects were the most investigated areas.
- Methodological biases were noted in both preclinical and clinical studies, particularly in group allocation and blinding.
Conclusions:
- Farnesol exhibits varied pharmacological and toxicological characteristics.
- The findings support farnesol's potential utility as an active pharmaceutical ingredient or a coadjuvant therapy.
- Further high-quality research is warranted to address identified methodological limitations.
More Related Videos
Related Concept Videos
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Pleural Disorders: Types and Brief Description
Eulerian and Lagrangian Flow Descriptions
The Eulerian method focuses on fixed points in space where fluid properties, such as velocity, pressure, and temperature, are observed as the fluid moves between these...
Random and Systematic Errors
Systematic Sampling Method
Systematic sampling is one of the simplest methods...

